Press release
Systemic Lupus Erythematosus Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AbbVie, GSK, Biogen, Idorsia, UCB, Roche, ImmuPharma, Eli Lilly, Provention Bio, AstraZeneca
"Systemic Lupus Erythematosus Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Systemic Lupus Erythematosus Therapeutics Market.
The report provides a detailed description of the Systemic Lupus Erythematosus drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Systemic Lupus Erythematosus Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/systemic-lupus-erythematosus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Systemic Lupus Erythematosus Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Systemic Lupus Erythematosus therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Systemic Lupus Erythematosus treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Systemic Lupus Erythematosus drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Systemic Lupus Erythematosus treatment market.
Learn More about the Clinical and Commercial Development Activities in the Systemic Lupus Erythematosus Therapeutics Domain:
https://www.delveinsight.com/report-store/systemic-lupus-erythematosus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Systemic Lupus Erythematosus Therapeutics Analysis
There is no complete cure for SLE currently, but there are many treatments available to help with particular symptoms. The disease involves a wide range of clinical features that encompasses vascular, immune, and fibrotic manifestations along with the involvement of many organs.
Treatments of SLE include NSAIDs and antimalarial agents, which are the first-line therapies for mild SLE. In addition, glucocorticoids and cytotoxic or immunosuppressive agents-such as azathioprine, mycophenolate mofetil, cyclophosphamide, cyclosporine, and methotrexate -are used for SLE with organ involvement. The current market possesses approved products such as BENLYSTA (belimumab) and SAPHNELO (anifrolumab-fnia).
There are approx. 55+ key companies developing therapies for Systemic Lupus Erythematosus. Currently, Roche is leading the therapeutics market with its Systemic Lupus Erythematosus drug candidates in the most advanced stage of clinical development.
Systemic Lupus Erythematosus Companies in the Therapeutics Market Include:
AbbVie, Akeso Biopharma, Alpine Immune Sciences, Amgen, Antengene Therapeutics, Aria Pharmaceuticals, Asahi Kasei Pharma, AstraZeneca, Athos Therapeutics, Biogen, Boston Pharmaceuticals, Brickell Biotech, Bristol-Myers Squibb (Celgene), Carna Bioscience, Chipscreen Biosciences, Citryll BV, Corbus Pharmaceuticals, Corestem, Daiichi Sankyo Company, Eisai, Eli Lilly and Company, Equillium, Exinda Thearapeutics, Genentech (Roche), Genovax, GlaxoSmithKline, Hoffmann-La Roche, Horizon Therapeutics, I-MAB Biopharma, Idorsia Pharmaceuticals, ILTOO, ImmuPharma, InnoCare, Janssen Research & Development, Kangpu Biopharmaceuticals, Kezar Life Sciences, Landos Biopharma, Medsenic, Merck KGaA, Neovacs, Novartis Pharmaceuticals, Pfizer, Provention Bio, Resolve, Resolve Therapeutics, Rheos Medicine, Roche, Sanofi, Sareum, Shanghai Junshi Biosciences, SinoMab Bioscience Ltd, Sorrento Therapeutics, UCB Pharma, Xencor, Yake Biotechnology, and others.
Emerging and Marketed Systemic Lupus Erythematosus Therapies Covered in the Report Include:
• ABBV-599: AbbVie
• Benlysta: GlaxoSmithKline
• BIIB059: Biogen
• Cenerimod: Idorsia Pharmaceuticals
• Dapirolizumab pegol: UCB Pharma
• Gazyva/Gazyvaro (obinutuzumab): Hoffmann-La Roche
• Lupuzor: ImmuPharma
• Olumiant (baricitinib): Eli Lilly
• PRV 3279: Provention Bio
• Saphnelo: AstraZeneca
And Many More
Get an in-depth Assessment of the Emerging Therapies and Systemic Lupus Erythematosus Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/systemic-lupus-erythematosus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Systemic Lupus Erythematosus Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Systemic Lupus Erythematosus pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Request for Sample PDF to Understand More About the Systemic Lupus Erythematosus Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/systemic-lupus-erythematosus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Systemic Lupus Erythematosus Current Treatment Patterns
4. Systemic Lupus Erythematosus - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Systemic Lupus Erythematosus Late-Stage Products (Phase-III)
7. Systemic Lupus Erythematosus Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Systemic Lupus Erythematosus Discontinued Products
13. Systemic Lupus Erythematosus Product Profiles
14. Systemic Lupus Erythematosus Companies
15. Systemic Lupus Erythematosus Drugs
16. Dormant and Discontinued Products
17. Systemic Lupus Erythematosus Unmet Needs
18. Systemic Lupus Erythematosus Future Perspectives
19. Systemic Lupus Erythematosus Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/systemic-lupus-erythematosus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Aneurysmal Subarachnoid Hemorrhage (SAH) Market
https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market
Dupuytren's Disease Market
https://www.delveinsight.com/report-store/dupuytrens-disease-market
Homocystinuria Market
https://www.delveinsight.com/report-store/homocystinuria-market-new
Platinum-Resistant Relapsed Ovarian Cancer Market
https://www.delveinsight.com/report-store/platinum-resistant-relapsed-ovarian-cancer-market
Dementia with Diabetes Market
https://www.delveinsight.com/report-store/dementia-with-diabetes-market-forecast
Pyruvate Kinase Deficiency Market
https://www.delveinsight.com/report-store/pyruvate-kinase-deficiency-market
Uterine Serous Carcinoma Market
https://www.delveinsight.com/report-store/uterine-serous-carcinoma-market
Paraganglioma Market
https://www.delveinsight.com/report-store/paraganglioma-market
Spinal Cord Stimulators (SCS) Global Market
https://www.delveinsight.com/report-store/spinal-cord-stimulator-market
Adult Spinal Deformity Market
https://www.delveinsight.com/report-store/adult-spinal-deformity-market
Age-related Vision Dysfunction Market
https://www.delveinsight.com/report-store/age-related-vision-dysfunction-market
Erythropoietic Protoporphyria Market
https://www.delveinsight.com/report-store/erythropoietic-protoporphyria-market
Juvenile Idiopathic arthritis (JIA) Market
https://www.delveinsight.com/report-store/juvenile-idiopathic-arthritis-jia-market
Otoscope Market
https://www.delveinsight.com/report-store/otoscope-market
Surgical Energy Generators Market
https://www.delveinsight.com/report-store/surgical-energy-generators-market
Eosinophilic Esophagitis Market
https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market
Hypereosinophilic Syndrome Market
https://www.delveinsight.com/report-store/hypereosinophilic-syndrome-market
Campylobacter Infections Market
https://www.delveinsight.com/report-store/campylobacter-infections-market
Degenerative Disc Disease Market
https://www.delveinsight.com/report-store/degenerative-disc-disease-ddd-market
Optic Neuritis Market
https://www.delveinsight.com/report-store/optic-neuritis-market
Shoulder Replacement Devices Global Market
https://www.delveinsight.com/report-store/shoulder-replacement-devices-market
Scleritis Market
https://www.delveinsight.com/report-store/scleritis-market
Polypoidal Choroidal Vasculopathy (PCV) Market
https://www.delveinsight.com/report-store/polypoidal-choroidal-vasculopathy-market
Post-Polycythemia Vera Myelofibrosis Market
https://www.delveinsight.com/report-store/post-polycythemia-vera-myelofibrosis-market
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Market
https://www.delveinsight.com/report-store/severe-acute-respiratory-syndrome-sars-coronavirus-infection-market
Cardiac Biomarkers Testing Devices Global Market
https://www.delveinsight.com/report-store/cardiac-biomarkers-testing-devices-market
Graves Orbitopathy Market
https://www.delveinsight.com/report-store/graves-orbitopathy-market
Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder Market
https://www.delveinsight.com/report-store/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Febrile Neutropenia Market
https://www.delveinsight.com/report-store/febrile-neutropenia-market
Axial Spondyloarthritis Market
https://www.delveinsight.com/report-store/axial-spondyloarthritis-market
Conductive Hearing Loss Market
https://www.delveinsight.com/report-store/conductive-hearing-loss-market
Metastatic Cutaneous Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/metastatic-cutaneous-squamous-cell-carcinoma-market
Ocular Melanoma Market
https://www.delveinsight.com/report-store/ocular-melanoma-market
Schistosomiasis Market
https://www.delveinsight.com/report-store/schistosomiasis-market
Adenosine Deaminase-Severe Combined Immunodeficiency Market
https://www.delveinsight.com/report-store/adenosine-deaminase-severe-combined-immunodeficiency-market
Dermal Erythema Market
https://www.delveinsight.com/report-store/dermal-erythema-market
Hypercalcemia Market
https://www.delveinsight.com/report-store/hypercalcemia-market
Marginal Zone Lymphoma Market
https://www.delveinsight.com/report-store/marginal-zone-lymphoma-market
Tonsillitis Market
https://www.delveinsight.com/report-store/tonsillitis-marke
Biliary Atresia Market
https://www.delveinsight.com/report-store/biliary-atresia-market
Endometrial Cancer Market
https://www.delveinsight.com/report-store/endometrial-cancer-market
Retinoblastoma Market
https://www.delveinsight.com/report-store/retinoblastoma-market
Dysautonomia (Autonomic Dysfunction) Market
https://www.delveinsight.com/report-store/dysautonomia-autonomic-dysfunction-market
IgA Nephropathy (IgAN) Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
Kyphoscoliosis Market
https://www.delveinsight.com/report-store/kyphoscoliosis-market
Myofascial Pain Syndrome Market
https://www.delveinsight.com/report-store/myofascial-pain-syndrome-market
Osteogenesis Imperfecta Market
https://www.delveinsight.com/report-store/osteogenesis-imperfecta-oi-market
Treatment-Resistant Depression (TRD) Market
https://www.delveinsight.com/report-store/treatment-resistant-depression-trd-market
Fallopian Tube Cancer Market
https://www.delveinsight.com/report-store/fallopian-tube-cancer-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Systemic Lupus Erythematosus Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AbbVie, GSK, Biogen, Idorsia, UCB, Roche, ImmuPharma, Eli Lilly, Provention Bio, AstraZeneca here
News-ID: 3246117 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Erythema
Industry Trends and Forecast for the Erythema Drug Market to 2030
"An international Erythema Drug Market report comprises of crucial aspects of the market that contains industry research, market sizing & forecast, competitive intelligence, market entry strategy, pricing trends, sustainability trends, customer insights, technology evolution, innovation trends, and distribution channel assessment. To prosper in this competitive market place, businesses are highly benefited if they adopt innovative solutions such as this market research report. Clients get clear understanding of the market…
Chemotherapy-Induced Acral Erythema Market Giants Spending Is Going to Boom
The Global Chemotherapy-Induced Acral Erythema Market Report by Absolute Markets Insights contains the market strategy, market orientation, expert opinion and knowledgeable information. It is an in-depth study analyzing the current state of the Chemotherapy-Induced Acral Erythema Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Chemotherapy-Induced Acral Erythema Market…
Facial Erythema Drugs Market Will Generate Record Revenue by 2029
Facial Erythema Drugs market is projected to grow at a CAGR of 5.5% from 2023 to 2029. The growth in this market can be attributed to the increasing prevalence of skin diseases, rising awareness about available treatment options, and the growing demand for minimally invasive procedures. One of the major benefits of referring Facial Erythema Drugs Market research is it provides latest trend analysis to allow key players understand as…
Erythema Treatment Market - Revive Your Glow, Embrace the Journey: Erythema Trea …
Newark, New Castle, USA - new report, titled Erythema Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Erythema Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Erythema Treatment market. The report offers an overview of the market, which…
Facial Erythema Drugs Market Will Generate Record Revenue by 2029
One of the major benefits of referring Facial Erythema DrugsMarket research is it provides latest trend analysis to allow key players understand as well as obtain best insights into market updates. It also aims at covering primary preferences of the customers and strategies that key players need to follow. Supportive and analytical data provided here greatly helps to examine the customer behavior. By having complete idea about customer behavior, it…
Global Facial Erythema Treatment Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Facial Erythema Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/817761/global-facial-erythema-treatment-market-insights
Drugs for Facial Erythema
The global Facial…
